SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,079.96 113.61
( 0.15%)

Global Indices

Nasdaq

53,790.86 -21.99
(-0.04%)

Dow Jones

7,769.71 20.51
(0.26%)

Hang Seng

68,341.16 817.10
(1.21%)

Nikkei 225

10,757.72 -75.43
(-0.70%)

Forex

USD-INR

95.38 0.10
(0.10%)

EUR-INR

110.06 0.02
(0.01%)

GBP-INR

128.81 0.17
(0.13%)

JPY-INR

0.60 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9559391

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

150.81

100073.46

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.67

Back

Tata Elxsi standalone net profit rises 18.17% in the June 2026 quarter

Jul 15,2026

Net profit of Tata Elxsi rose 18.17% to Rs 170.60 crore in the quarter ended June 2026 as against Rs 144.37 crore during the previous quarter ended June 2025. Sales rose 14.46% to Rs 1021.11 crore in the quarter ended June 2026 as against Rs 892.10 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1021.11	892.10	14
OPM %	21.15	20.93	-
PBDT	254.72	220.62	15
PBT	232.45	196.35	18
NP	170.60	144.37	18

78,079.96 113.61 ( 0.15%)

53,790.86 -21.99 (-0.04%)

7,769.71 20.51 (0.26%)

68,341.16 817.10 (1.21%)

10,757.72 -75.43 (-0.70%)

95.38 0.10 (0.10%)

110.06 0.02 (0.01%)

128.81 0.17 (0.13%)

0.60 0.00 (-0.21%)